Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Companies  >  All News

News : Companies
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

Cobra Biologics : Receives the Queen's Award for Enterprise in International Trade

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/21/2018 | 04:01am EDT

The UK’s most prestigious business award granted in recognition of outstanding achievement in the export of services for gene and immunotherapy products.

Cobra Biologics (“Cobra”) a leading international contract development and manufacturing organisation (“CDMO”), today announced that it has been awarded the Queen’s Award 2018 for Enterprise, in the International Trade category. The prestigious award is in recognition of Cobra’s commercial success in providing services to its global customer base.

Now in their 53rd year, the Queen’s Awards have a long history of recognising exceptional UK businesses and Cobra will be attending a reception at Buckingham Palace followed by a presentation of the Award by a representative of Her Majesty The Queen at Cobra’s UK facility later in the year.

Cobra has a 20 year track record of supporting the life science industry with contract development and manufacturing of biopharmaceuticals, from preclinical through to clinical trials and commercial supply and currently exports over 85% of its services from its facilities based in the UK and Sweden.

Cobra’s UK based GMP approved facility is a globally recognised centre of excellence for the development and production of biological material to support both gene- and immuno-therapy. In April 2017, Cobra announced a £15 million gene therapy expansion plan, to meet the increased demand from both plasmid DNA and viral vectors for Phase III and Commercial supply to support both existing and new customer requirements in the development of revolutionary disease therapies.

Peter Coleman, Chief Executive of Cobra Biologics, commented: “I am immensely proud of what Cobra has achieved over the last few years, culminating in the Queen’s Award. International Trade is vitally important for Cobra and the work that we do is challenging and requires a committed work force whose skills and dedication attract business from all over the world. I would like also to thank the Office for Life Science, Innovate UK and the Department for International Trade for their support of our expansion plans in the UK.”

ENDS


© Business Wire 2018
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
08:07pCOSCO SHIPPING PORTS : (1) discloseable transaction - disposal of interest in various port assets and (2) possible disposal of taicang terminal and jiangsu petrochemical terminal
PU
08:07pDEADLINE ALERT : Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Oasmia Pharmaceutical AB (NASDAQ: OASM) and Encourages Oasmia Investors to Contact the Firm
PR
08:02pBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sarepta Therapeutics, Canada Goose, and Meredith Corporation and Encourages Investors to Contact the Firm
GL
08:01pKirby McInerney LLP Continues Investigation of Shareholder Claims Against The RealReal, Inc.
BU
07:57pPALADIN ENERGY : Appendix 3B - Placement
PU
07:57pFAR EAST CONSORTIUM INTERNATIONAL : Discloseable transaction formation of joint ventures for acquisition of hotel in singapore
PU
07:57pPW MEDTECH : Major transaction and inside information disposal of cbpo shares, entering into the consortium agreement and submission of the preliminary non-binding privatization proposal
PU
07:57pTrilogy International Partners Inc. Sets Date to Report Third Quarter 2019 Results
GL
07:53pBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Curaleaf, 2U, Granite Construction, and Pluralsight and Encourages Investors to Contact the Firm
GL
07:52pPERPETUAL : Private wins Best Multi Strategy Fund second year in a row
PU
Latest news "Companies"